指南与共识急腹症与外科感染围术期管理与 ERAS胃肠外科

SAGES 2022 指南:COVID-19 大流行期间腹腔镜的使用

SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19.
指南 / 共识 · Surg Endosc · 2022-03-02

SAGES 基于两项关键问题的系统综述制定 2022 指南,评估 COVID-19 大流行期间微创手术对手术室人员的安全性。共筛选 1361 篇和 977 篇文献,分别仅 2 篇和 4 篇符合纳入标准。现有证据显示腹腔镜与开腹手术的手术室人员阳性率相似,腹腔镜患者围术期死亡率更低;手术烟雾中可检测到 SARS-CoV-2 颗粒。

要点

  • 腹腔镜与开腹手术在 COVID 阳性患者中手术室人员阳性率相似
  • 腹腔镜手术患者围术期死亡率低于开腹手术
  • 腹腔镜手术烟雾中可检测到 SARS-CoV-2 颗粒,需采取措施防止手术室人员暴露

核心结论

  • 腹腔镜与开腹手术对手术室人员暴露相当,且腹腔镜在死亡率方面非劣于开腹,因此 COVID-19 患者腹部手术可选择腹腔镜或开腹入路。
  • 所有腹腔镜或开腹手术均应采取措施防止手术室人员暴露于手术烟雾,因烟雾中可能存在病毒。

研究设计与样本

  • SAGES 针对两项关键问题(KQ)进行系统文献综述,报告遵循 PRISMA 标准,由主题专家通过叙述性综合形成循证推荐,并提出未来研究方向。
  • KQ1 共审查 1361 篇文章,2 篇符合纳入标准;KQ2 共审查 977 篇文章,4 篇符合纳入标准,其中 2 项研究专门报告 SARS-CoV-2 病毒。

主要发现

  • 尽管该领域发表大量文献,但缺乏良好对照且无偏倚的数据来支持推荐。
  • 现有数据显示,COVID 阳性患者中腹腔镜与开腹手术的手术室人员阳性率相似;但腹腔镜手术患者的围术期死亡率低于开腹手术。
  • 腹腔镜手术烟雾中已检测到 SARS-CoV-2 颗粒。

关键数值与推荐

  • 推荐:COVID-19 患者腹部手术可采用腹腔镜或开腹入路(基于手术室人员暴露等效及腹腔镜死亡率非劣效)。
  • 推荐:所有腹腔镜或开腹病例均应采取措施防止手术室人员暴露于手术烟雾(因病毒可能存在于烟雾中)。

临床怎么用

  • 对 SARS-CoV-2 感染或疑似患者行腹部手术时,腹腔镜与开腹入路均可选择。
  • 无论采用腹腔镜还是开腹手术,均应实施措施防止手术室人员暴露于手术烟雾。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: SARS-CoV-2 has changed global healthcare since the pandemic began in 2020. The safety of minimally invasive surgery (MIS) utilizing insufflation from the standpoint of safety to the operating room personnel is currently being explored. The aims of this guideline are to examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved. METHODS: Systematic literature reviews were conducted for 2 key questions (KQ) regarding the safety of MIS in the setting of COVID-19 pandemic. Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis criteria. Evidence-based recommendations were formulated using a narrative synthesis of the literature by subject experts. Recommendations for future research were also proposed. RESULTS: In KQ1, a total of 1361 articles were reviewed, with 2 articles meeting inclusion. In KQ2, a total of 977 articles were reviewed, with 4 articles met inclusions criteria, of which 2 studies reported on the SARS-CoV2 virus specifically. Despite many publications in the field, very little well-controlled and unbiased data exist to inform the recommendations. Of that which is available, it shows that both laparoscopic and open operations in Covid-positive patients had similar rates of OR staff positivity rates; however, patients who underwent laparoscopic procedures had a lower perioperative mortality than open procedures. Also, SARS-CoV-2 particles have been detected in the surgical plume at laparoscopy. CONCLUSION: With demonstrated equivalence of operating room staff exposure, and noninferiority of laparoscopic access with respect to mortality, either laparoscopic or open approaches to abdominal operations may be used in patients with SARS-CoV-2. Measures should be employed for all laparoscopic or open cases to prevent exposure of operating room staff to the surgical plume, as virus can be present in this plume.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Collings AT, Jeyarajah DR, Hanna NM, et al. SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19. Surg Endosc. 2022. PMID: 35237900. doi:10.1007/s00464-022-09133-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。